Chemotherapy - Peripheral Neuropathy Study (07.06.122)
URCC 07004: Assessment Of Topical Treatment Response With Amitriptyline And Ketamine: Combination Trial In Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Protocol ID
07.06.122
Protocol Description
The purpose of this study is to determine if a cream called EpiCept-NP-1® is effective, safe and tolerable when applied to the skin of people with chemotherapy-associated peripheral neuropathy.
Eligibility Criteria
Patients undergoing chemotherapy
Primary Investigator(s)
- James D'Olimpio, MD